Good practices for adaptive clinical trials in pharmaceutical product development

Brenda Gaydos, Keaven M. Anderson, Donald Berry, Nancy Burnham, Christy Chuang-Stein, Jennifer Dudinak, Parvin Fardipour, Paul Gallo, Sam Givens, Roger Lewis, Jeff Maca, José Pinheiro, Yili Pritchett, Michael Krams

Research output: Contribution to journalReview articlepeer-review

64 Scopus citations

Abstract

This article is a summary of good adaptive practices for the planning and implementation of adaptive designs compiled from experiences gained in the pharmaceutical industry. The target audience is anyone involved in the planning and execution of clinical trials. The first step prior to planning an adaptive design is to assess the appropriateness of its use. Hence, strategic points to consider when assessing if an adaptive design is the right choice for a trial are discussed. In addition, strategic points for consideration at the design and implementation stage are included from operational, regulatory, clinical, and statistical perspectives. Good practices for trial simulation, trial documentation, and data monitoring committees are provided.

Original languageEnglish (US)
Pages (from-to)539-556
Number of pages18
JournalDrug Information Journal
Volume43
Issue number5
DOIs
StatePublished - Sep 2009

Keywords

  • Adaptive design
  • Best practices
  • Flexible design
  • Implementation
  • Planning

ASJC Scopus subject areas

  • Pharmacology (nursing)
  • Drug guides
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Good practices for adaptive clinical trials in pharmaceutical product development'. Together they form a unique fingerprint.

Cite this